Filing Details
- Accession Number:
- 0001702626-19-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 11:40:28
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-25 11:40:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270074 | R David Strayer | 604 Main Street Riverton NJ 08077 | Chief Science/Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-21 | 2,481 | $4.03 | 5,420 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Previous Balance of the amount of Securities Owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019.
Billionaire Hedge Funds
